deoxyuridine has been researched along with valproic acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Dantzig, AH; Donoho, GP; Durland-Busbice, S; Perkins, EJ; Pratt, SE; Shepard, RL; Starling, JJ; Wickremsinhe, ER | 1 |
| Chou, A; Foti, SB; Moll, AD; Roskams, AJ | 1 |
3 other study(ies) available for deoxyuridine and valproic acid
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Efficacy of low-dose oral metronomic dosing of the prodrug of gemcitabine, LY2334737, in human tumor xenografts.
Topics: Administration, Metronomic; Administration, Oral; Animals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Deoxyuridine; Disease Models, Animal; Dose-Response Relationship, Drug; Gemcitabine; Gene Expression; HCT116 Cells; Humans; Lung Neoplasms; Mice; Prodrugs; Valproic Acid; Xenograft Model Antitumor Assays | 2013 |
HDAC inhibitors dysregulate neural stem cell activity in the postnatal mouse brain.
Topics: Age Factors; Animals; Animals, Newborn; Brain; Bromodeoxycytidine; Cell Differentiation; Cells, Cultured; Deoxycytidine; Deoxyuridine; Dose-Response Relationship, Drug; Gene Expression Regulation, Developmental; Histone Deacetylase 1; Histone Deacetylase 2; Histone Deacetylase Inhibitors; Mice; Nerve Tissue Proteins; Neural Stem Cells; Neurogenesis; Proliferating Cell Nuclear Antigen; SOXB1 Transcription Factors; Valproic Acid | 2013 |